Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|June 6, 2018
Pure laparoscopic pancreas parenchymal dissection using CUSA for distal pancreatectomyKeiichi Okano, Hironobu Suto, Minoru Oshima, et al.
Surgical Case Reports|October 2, 2020
Four cases of laparoscopic colectomy for sigmoid colon and rectal cancer with persistent descending mesocolonYumi Furuichi, Kensuke Kumamoto, Eisuke Asano, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|May 20, 2011
Persisting ratio of total amylase output in drain fluid can predict postoperative clinical pancreatic fistulaKeiichi Okano, Keitaro Kakinoki, Hironobu Suto, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 28, 2022
Efficacy of neoadjuvant chemoradiotherapy followed by pancreatic resection for older patients with resectable and borderline resectable pancreatic ductal adenocarcinomaHironobu Suto, Minoru Oshima, Yasuhisa Ando, et al.
World Journal of Surgery|March 6, 2024
A combined score for predicting clinically relevant postoperative pancreatic fistula based on inflammatory parameters and drainage fluid culture results on postoperative day 3Hironobu Suto, Hiroyuki Matsukawa, Yasuhisa Ando, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 21, 2024
Tumor location, clinicopathological features, and perioperative and prognostic outcomes in patients who underwent pancreatic resection following neoadjuvant chemoradiotherapy for resectable pancreatic cancer: A retrospective studyHironobu Suto, Hiroyuki Matsukawa, Takuro Fuke, et al.
Journal of Gastroenterology|June 22, 2026
Paired tumor-normal metabolomic profiling reveals alterations in choline phospholipid precursor metabolism in biliary tract cancerHironobu Suto, Kensuke Kumamoto, Mina Nagao, et al.
Annals of Surgical Oncology|November 18, 2025
A Phase II Study of Short-Course Neoadjuvant Chemoradiotherapy with Gemcitabine, S-1, and Hypofractionated Radiotherapy for Resectable and Borderline Resectable Pancreatic Ductal AdenocarcinomaHironobu Suto, Minoru Oshima, Yasuhisa Ando, et al.
Pancreas|May 18, 2022
Efficacy and Safety of Neoadjuvant Chemoradiation Therapy Administered for 5 Versus 2 Weeks for Resectable and Borderline Resectable Pancreatic CancerHironobu Suto, Keiichi Okano, Minoru Oshima, et al.
Japanese Journal of Clinical Oncology|March 29, 2018
18F-fluorodeoxyglucose positron emission tomography to indicate conversion surgery in patients with initially unresectable locally advanced pancreatic cancerKeiichi Okano, Hironobu Suto, Minoru Oshima, et al.
Pageof 6